Chunlai Lu

2.2k total citations · 1 hit paper
41 papers, 1.4k citations indexed

About

Chunlai Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chunlai Lu has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Chunlai Lu's work include RNA modifications and cancer (8 papers), Esophageal Cancer Research and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Chunlai Lu is often cited by papers focused on RNA modifications and cancer (8 papers), Esophageal Cancer Research and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Chunlai Lu collaborates with scholars based in China, United States and Singapore. Chunlai Lu's co-authors include Jie Gu, Fengkai Xu, Di Ge, Qiaoliang Zhu, Di Ge, Yiwei Chu, Guangyin Zhao, Zongwu Lin, Siying Wang and Qiaozhu Zuo and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chunlai Lu

40 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity

2021 416 citations Botai Li, Lili Zhu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chunlai Lu China	19	964	567	329	311	177	41	1.4k
Yeqing Angela Yang United States	13	1.2k 1.2×	774 1.4×	333 1.0×	441 1.4×	261 1.5×	17	1.8k
Qingfu Zhang China	22	816 0.8×	531 0.9×	377 1.1×	376 1.2×	128 0.7×	63	1.4k
Bernhard Barleon Germany	14	1.3k 1.3×	577 1.0×	421 1.3×	198 0.6×	166 0.9×	17	1.7k
Takahiro Gotoh Japan	17	710 0.7×	308 0.5×	313 1.0×	360 1.2×	120 0.7×	27	1.2k
Federica Facchinetti Italy	15	1.0k 1.1×	636 1.1×	327 1.0×	328 1.1×	78 0.4×	24	1.5k
Awad Jarrar United States	14	651 0.7×	350 0.6×	736 2.2×	265 0.9×	145 0.8×	26	1.5k
Carlo Dominici Italy	27	1.2k 1.2×	608 1.1×	445 1.4×	383 1.2×	127 0.7×	57	1.9k
Angela Celetti Italy	27	1.0k 1.0×	221 0.4×	561 1.7×	260 0.8×	115 0.6×	44	1.5k
Stine H. Kresse Norway	21	877 0.9×	604 1.1×	350 1.1×	443 1.4×	98 0.6×	30	1.5k
Arne Östman Sweden	11	527 0.5×	228 0.4×	337 1.0×	143 0.5×	158 0.9×	14	1.0k

Countries citing papers authored by Chunlai Lu

Since Specialization

Citations

This map shows the geographic impact of Chunlai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlai Lu more than expected).

Fields of papers citing papers by Chunlai Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlai Lu. The network helps show where Chunlai Lu may publish in the future.

Co-authorship network of co-authors of Chunlai Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlai Lu. A scholar is included among the top collaborators of Chunlai Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlai Lu. Chunlai Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yin, et al.. (2024). Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment. Journal of Inflammation Research. Volume 17. 101–119. 3 indexed citations

Fu, Lili, Bo Yang, Chenchen Zhou, et al.. (2024). Integrated mRNA-seq and miRNA-seq analysis reveals key transcription factors of HNF4α and KLF4 in ADPKD. Biochemical and Biophysical Research Communications. 735. 150848–150848. 3 indexed citations

Zhang, Hongyu, Haoyu Wen, Qiaoliang Zhu, et al.. (2024). Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma. EBioMedicine. 100. 104971–104971. 8 indexed citations

Cheng, Zhuoan, Chunlai Lu, Hui Wang, et al.. (2022). Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression. Cancer Letters. 531. 1–13. 30 indexed citations

Yang, Huiqin, Xing Jin, Tao Cheng, et al.. (2022). Comprehensive Genome-Scale Analysis of Esophageal Carcinoma With Esophageal Tissue-Resident Micro-Environment Discrepancy. Frontiers in Microbiology. 13. 859352–859352. 1 indexed citations

Li, Botai, Lili Zhu, Chunlai Lu, et al.. (2021). circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nature Communications. 12(1). 295–295. 416 indexed citations breakdown →

Li, Yin, Jie Gu, Fengkai Xu, et al.. (2019). Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma.. PubMed Central. 11(4). 1997–2012. 16 indexed citations

Zhu, Qiaoliang, Rongkui Luo, Jie Gu, et al.. (2019). High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. Journal of Cancer. 11(4). 810–818. 9 indexed citations

Xu, Fengkai, Jie Gu, Chunlai Lu, et al.. (2018). Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway. International Journal of Biological Sciences. 15(1). 127–137. 28 indexed citations

10.

Xu, Fengkai, Jie Gu, Lin Wang, et al.. (2018). Up-regulation Of EIF3e Is Associated With The Progression Of Esophageal Squamous Cell Carcinoma And Poor Prognosis In Patients. Journal of Cancer. 9(7). 1135–1144. 7 indexed citations

11.

Gu, Jie, Wei Mao, Fengkai Xu, et al.. (2018). Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. Cancer Letters. 443. 125–134. 48 indexed citations

12.

Xi, Junjie, Jiacheng Yin, Lin Wang, et al.. (2018). A surveillance method-oriented detection of post-operative spatial-temporal recurrence for non-small cell lung cancer. Journal of Thoracic Disease. 10(11). 6107–6117. 4 indexed citations

13.

Lu, Chunlai, Di Ge, Yunfeng Yuan, et al.. (2016). Pedicle muscle flap transposition for chronic empyema with persistent bronchopleural fistula: experience of a single clinical center in China. Surgery Today. 46(10). 1132–1137. 9 indexed citations

14.

Guo, Jing, Jie Gu, Zongwu Lin, et al.. (2015). Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer. Tumor Biology. 37(5). 6371–6378. 27 indexed citations

15.

Gu, Jie, Fengkai Xu, Guangyin Zhao, et al.. (2015). Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2. Medical Oncology. 32(3). 51–51. 25 indexed citations

16.

Lu, Chunlai, Fengkai Xu, Jie Gu, et al.. (2015). Clinical and biological significance of stem-like CD133+CXCR4+ cells in esophageal squamous cell carcinoma. Journal of Thoracic and Cardiovascular Surgery. 150(2). 386–395. 38 indexed citations

17.

Lin, Zongwu, Jie Gu, Ronghua Liu, et al.. (2014). Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma. Tumor Biology. 35(11). 10959–10968. 7 indexed citations

18.

Zhao, Guangyin, Zongwu Lin, Chunlai Lu, et al.. (2014). USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma. Tumor Biology. 36(3). 1721–1729. 68 indexed citations

19.

Yuan, Yunfeng, Chunlai Lu, Liang Xue, & Di Ge. (2014). Association between TERT rs2736100 polymorphism and lung cancer susceptibility: evidence from 22 case–control studies. Tumor Biology. 35(5). 4435–4442. 6 indexed citations

20.

Lu, Chunlai, Weigang Guo, Jianyong Ding, & Di Ge. (2008). Clinical and pathological analysis of solitary fibrous tumor of the pleura. 24(2). 91–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact